38.21
4.33%
-1.73
시간 외 거래:
38.21
Celldex Therapeutics Inc. (CLDX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
172.31%
4.131
|
1.517 | 0.268 | 0.967 | 1.613 |
Operating Expenses
|
20.35%
51.46
|
42.76 | 33.47 | 33.44 | 29.40 |
Benefits Costs and Expenses |
9.62%
38.65
|
42.76 | 33.47 | 33.44 | 28.10 |
Costs And Expenses |
21.05%
51.76
|
42.76 | 33.47 | 33.44 | 29.50 |
Operating Income/Loss |
15.49%
-47.63
|
-41.24 | -33.20 | -32.47 | -27.89 |
Income/Loss From Continuing Operations Before Tax |
16.31%
-34.51
|
-41.24 | -30.50 | -29.36 | -26.49 |
Income/Loss From Continuing Operations After Tax |
81.08%
-7.239
|
-38.26 | -30.50 | -29.36 | -9.003 |
Net Income/Loss
|
13.19%
-43.31
|
-38.26 | -30.50 | -29.36 | -26.49 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
97.45%
0.00121
|
0.0473 | 0.0473 | 0.0472 | -46.76 |
Diluted Average Shares |
97.45%
0.00121
|
0.0473 | 0.0473 | 0.0472 | -46.76 |
Basic Earnings Per Share |
3.70%
-0.84
|
-0.81 | -0.65 | -0.62 | -0.57 |
Diluted Earnings Per Share |
3.70%
-0.84
|
-0.81 | -0.65 | -0.62 | -0.57 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):